Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tat peptide-mediated intracellular delivery of liposomes.

× No keyword cloud information.

13 in total

Review 1. Ligand-targeted delivery of therapeutic siRNA.

Authors: Yutaka Ikeda; Kazunari Taira
Journal: Pharm Res Date: 2006-08 Impact factor: 4.200

Review 2. Nanosystems for simultaneous imaging and drug delivery to T cells.

Authors: Tarek M Fahmy; Peter M Fong; Jason Park; Todd Constable; W Mark Saltzman
Journal: AAPS J Date: 2007-06-08 Impact factor: 4.009

3. Folate and TAT peptide co-modified liposomes exhibit receptor-dependent highly efficient intracellular transport of payload in vitro and in vivo.

Authors: Yaqin Zhu; Liang Cheng; Lifang Cheng; Fazhen Huang; Qing Hu; Ling Li; Chenmin Tian; Lin Wei; Dawei Chen
Journal: Pharm Res Date: 2014-05-24 Impact factor: 4.200

4. Targeting ischemic penumbra Part II: selective drug delivery using liposome technologies.

Authors: Shimin Liu; Steven R Levine; H Richard Winn
Journal: J Exp Stroke Transl Med Date: 2011

Review 5. Nanovehicular intracellular delivery systems.

Authors: Ales Prokop; Jeffrey M Davidson
Journal: J Pharm Sci Date: 2008-09 Impact factor: 3.534

6. Enhanced cytotoxicity of TATp-bearing paclitaxel-loaded micelles in vitro and in vivo.

Authors: Rupa R Sawant; Vladimir P Torchilin
Journal: Int J Pharm Date: 2009-03-27 Impact factor: 5.875

7. The architecture of ligand attachment to nanocarriers controls their specific interaction with target cells.

Authors: Rupa R Sawant; Rishikesh M Sawant; Amit A Kale; Vladimir P Torchilin
Journal: J Drug Target Date: 2008-08 Impact factor: 5.121

8. Tat peptide is capable of importing large nanoparticles across nuclear membrane in digitonin permeabilized cells.

Authors: Nitin Nitin; Leslie LaConte; Won Jong Rhee; Gang Bao
Journal: Ann Biomed Eng Date: 2009-08-06 Impact factor: 3.934

Review 9. Multifunctional and stimuli-sensitive pharmaceutical nanocarriers.

Authors: Vladimir Torchilin
Journal: Eur J Pharm Biopharm Date: 2008-10-17 Impact factor: 5.571

10. Doxorubicin in TAT peptide-modified multifunctional immunoliposomes demonstrates increased activity against both drug-sensitive and drug-resistant ovarian cancer models.

Authors: Anjali Apte; Erez Koren; Alexander Koshkaryev; Vladimir P Torchilin
Journal: Cancer Biol Ther Date: 2013-10-21 Impact factor: 4.742